Apex Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $745K | Buy |
13,918
+4,796
| +53% | +$257K | 0.02% | 210 |
|
|
2015
Q4 | $599K | Hold |
9,122
| – | – | 0.01% | 206 |
|
|
2015
Q3 | $515K | Sell |
9,122
-160
| -2% | -$9.03K | 0.01% | 214 |
|
|
2015
Q2 | $549K | Sell |
9,282
-27
| -0.3% | -$1.6K | 0.01% | 219 |
|
|
2015
Q1 | $580K | Buy |
9,309
+544
| +6% | +$33.9K | 0.01% | 211 |
|
|
2014
Q4 | $504K | Sell |
8,765
-3,845
| -30% | -$221K | 0.01% | 217 |
|
|
2014
Q3 | $678K | Buy |
12,610
+160
| +1% | +$8.6K | 0.02% | 192 |
|
|
2014
Q2 | $653K | Buy |
12,450
+1,350
| +12% | +$70.8K | 0.02% | 199 |
|
|
2014
Q1 | $587K | Hold |
11,100
| – | – | 0.02% | 202 |
|
|
2013
Q4 | $445K | Buy |
11,100
+5,400
| +95% | +$216K | 0.02% | 210 |
|
|
2013
Q3 | $215K | Buy |
+5,700
| New | +$215K | 0.01% | 224 |
|